Procept Total Current Assets from 2010 to 2026
| PRCT Stock | USD 28.09 0.41 1.44% |
Total Current Assets | First Reported 2020-09-30 | Previous Quarter 457.7 M | Current Value 454.2 M | Quarterly Volatility 113.2 M |
Check Procept Biorobotics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Procept Biorobotics' main balance sheet or income statement drivers, such as Net Interest Income of 8.1 M, Interest Income of 13.2 M or Depreciation And Amortization of 3.6 M, as well as many indicators such as Price To Sales Ratio of 20.42, Dividend Yield of 0.0 or PTB Ratio of 18.47. Procept financial statements analysis is a perfect complement when working with Procept Biorobotics Valuation or Volatility modules.
Procept | Total Current Assets | Build AI portfolio with Procept Stock |
The evolution of Total Current Assets for Procept Biorobotics Corp provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Procept Biorobotics compares to historical norms and industry peers.
Latest Procept Biorobotics' Total Current Assets Growth Pattern
Below is the plot of the Total Current Assets of Procept Biorobotics Corp over the last few years. It is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. Procept Biorobotics' Total Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Procept Biorobotics' overall financial position and show how it may be relating to other accounts over time.
| Total Current Assets | 10 Years Trend |
|
Total Current Assets |
| Timeline |
Procept Total Current Assets Regression Statistics
| Arithmetic Mean | 170,033,827 | |
| Geometric Mean | 106,241,693 | |
| Coefficient Of Variation | 101.22 | |
| Mean Deviation | 147,869,659 | |
| Median | 50,358,000 | |
| Standard Deviation | 172,101,088 | |
| Sample Variance | 29618.8T | |
| Range | 503.8M | |
| R-Value | 0.82 | |
| Mean Square Error | 10420.8T | |
| R-Squared | 0.67 | |
| Significance | 0.000059 | |
| Slope | 27,899,898 | |
| Total Sum of Squares | 473900.5T |
Procept Total Current Assets History
About Procept Biorobotics Financial Statements
Procept Biorobotics shareholders use historical fundamental indicators, such as Total Current Assets, to determine how well the company is positioned to perform in the future. Although Procept Biorobotics investors may analyze each financial statement separately, they are all interrelated. The changes in Procept Biorobotics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Procept Biorobotics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Current Assets | 554.1 M | 291.8 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Procept Stock Analysis
When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.